Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Aug-12 6:36 PM View:  | Beck Teresa Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 8,000 | $31.00 | $248,000.00 | (100%) 8.0K to 0 | |
| 10-Aug-12 6:35 PM View: | Costa Paulo F Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 26,000 | $31.00 | $806,000.00 | (100%) 26.0K to 0 | |
| 10-Aug-12 6:37 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 20,742 | $31.00 | $642,993.00 | (100%) 20.74K to 0 | |
| 10-Aug-12 6:39 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 125,181 | $31.00 | $3,880,620.00 | (100%) 125.18K to 0 | |
| 10-Aug-12 6:38 PM View: | Lloyd Marcea Bland SVP, Chief Administrative Offi | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 62,469 | $31.00 | $1,936,550.00 | (86%) 72.53K to 10.06K | |
| 10-Aug-12 6:35 PM View: | Sullivan Joseph P Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 6,000 | $31.00 | $186,000.00 | (100%) 6.0K to 0 | |
| 10-Aug-12 6:38 PM View: | Mihalik Vincent P SVP, Chief Commercial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 39,917 | $31.00 | $1,237,430.00 | (87%) 45.77K to 5.86K | |
| 10-Aug-12 6:38 PM View: | Marshall Paul SVP, Operations | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 31,723 | $31.00 | $983,413.00 | (76%) 41.8K to 10.08K | |
| 10-Aug-12 6:37 PM View: | Gergen Mark J SVP, Corporate Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Acquisition (other) | 53,181 | $31.00 | $1,648,610.00 | 71% 75.33K to 128.51K | |
| 10-Aug-12 6:35 PM View: | Skyler Jay S Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 98,286 | $31.00 | $3,046,870.00 | (66%) 148.16K to 49.88K | |
| 10-Aug-12 6:34 PM View: | Behrens M Kathleen Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 6,000 | $31.00 | $186,000.00 | (100%) 6.0K to 0 | |
| 10-Aug-12 6:37 PM View: | Gergen Mark J SVP, Corporate Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 64,750 | $31.00 | $2,007,260.00 | (86%) 75.33K to 10.58K | |
| 10-Aug-12 6:37 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Acquisition (other) | 71,349 | $31.00 | $2,211,820.00 | 33% 213.3K to 284.65K | |
| 10-Aug-12 6:37 PM View: | Weyer Christian SVP, Research & Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 34,207 | $31.00 | $1,060,400.00 | (78%) 43.88K to 9.67K | |
| 10-Aug-12 6:35 PM View: | Denner Alexander J Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 10,161 | $31.00 | $314,991.00 | (100%) 10.16K to 0 | |
| 10-Aug-12 6:38 PM View: | Leonhardt Harry J SVP, Legal, Compl & Corp Secty | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 38,705 | $31.00 | $1,199,860.00 | (83%) 46.82K to 8.11K | |
| 10-Aug-12 6:36 PM View: | Adams Adrian Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 21,000 | $31.00 | $651,000.00 | (100%) 21.0K to 0 | |
| 10-Aug-12 6:39 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Acquisition (other) | 215,526 | $31.00 | $6,681,310.00 | 97% 223.13K to 438.65K | |
| 10-Aug-12 6:38 PM View: | Lloyd Marcea Bland SVP, Chief Administrative Offi | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 10,061 | $31.00 | $311,897.00 | (100%) 10.06K to 0 | |
| 10-Aug-12 6:39 PM View: | Foletta Mark G SVP, Chief Financial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Acquisition (other) | 64,702 | $31.00 | $2,005,760.00 | 76% 85.32K to 150.03K | |
| 10-Aug-12 6:38 PM View: | Mihalik Vincent P SVP, Chief Commercial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 5,858 | $31.00 | $181,586.00 | (100%) 5.86K to 0 | |
| 10-Aug-12 6:36 PM View: | Eastham Karin Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 6,000 | $31.00 | $186,000.00 | (100%) 6.0K to 0 | |
| 10-Aug-12 6:39 PM View: | Foletta Mark G SVP, Chief Financial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 73,370 | $31.00 | $2,274,470.00 | (86%) 85.32K to 11.95K | |
| 10-Aug-12 6:38 PM View: | Marshall Paul SVP, Operations | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 10,080 | $31.00 | $312,468.00 | (100%) 10.08K to 0 | |
| 10-Aug-12 6:37 PM View: | Gergen Mark J SVP, Corporate Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 53,181 | $31.00 | $1,648,610.00 | (41%) 128.51K to 75.33K | |
| 10-Aug-12 6:39 PM View: | Rowland Lloyd A VP, Chief Compliance Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 35,426 | $31.00 | $1,098,210.00 | (75%) 47.06K to 11.64K | |
| 10-Aug-12 6:35 PM View: | Skyler Jay S Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 49,876 | $31.00 | $1,546,160.00 | (100%) 49.88K to 0 | |
| 10-Aug-12 6:37 PM View: | Gergen Mark J SVP, Corporate Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 10,583 | $31.00 | $328,085.00 | (100%) 10.58K to 0 | |
| 10-Aug-12 6:37 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 71,349 | $31.00 | $2,211,820.00 | (25%) 284.65K to 213.3K | |
| 10-Aug-12 6:37 PM View: | Weyer Christian SVP, Research & Development | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 9,672 | $31.00 | $299,832.00 | (100%) 9.67K to 0 | |
| 10-Aug-12 6:37 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 192,561 | $31.00 | $5,969,390.00 | (90%) 213.3K to 20.74K | |
| 10-Aug-12 6:38 PM View: | Leonhardt Harry J SVP, Legal, Compl & Corp Secty | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 8,113 | $31.00 | $251,491.00 | (100%) 8.11K to 0 | |
| 10-Aug-12 6:39 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 215,526 | $31.00 | $6,681,310.00 | (49%) 438.65K to 223.13K | |
| 10-Aug-12 6:39 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 97,945 | $31.00 | $3,036,300.00 | (44%) 223.13K to 125.18K | |
| 10-Aug-12 6:39 PM View: | Foletta Mark G SVP, Chief Financial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 64,702 | $31.00 | $2,005,760.00 | (43%) 150.02K to 85.32K | |
| 10-Aug-12 6:36 PM View: | Gavin James R III Director | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 4,580 | $31.00 | $141,980.00 | (100%) 4.58K to 0 | |
| 10-Aug-12 6:39 PM View: | Foletta Mark G SVP, Chief Financial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (change in control) | 11,953 | $31.00 | $370,531.00 | (100%) 11.95K to 0 | |
| 10-Aug-12 6:39 PM View: | Rowland Lloyd A VP, Chief Compliance Officer | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 11,639 | $31.00 | $360,821.00 | (100%) 11.64K to 0 | |
| 26-Jul-12 8:06 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 26-Jul-12 | Payment of Exercise | 13,392 | $30.80 | $412,407.00 | (6%) 226.69K to 213.3K | (< 1%) |
| 26-Jul-12 8:06 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 26-Jul-12 | Option Exercise | 20,300 | $11.95 | $242,585.00 | 10% 206.39K to 226.69K | |
| 26-Jul-12 8:05 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 26-Jul-12 | Option Exercise | 36,000 | $11.95 | $430,200.00 | 17% 211.38K to 247.38K | |
| 26-Jul-12 8:05 PM View: | Bradbury Daniel President & Chief Executive Of | Amylin Pharmaceuticals Inc. (AMLN) | 26-Jul-12 | Payment of Exercise | 24,252 | $30.80 | $746,840.00 | (10%) 247.38K to 223.13K | (< 1%) |
| 26-Jul-12 8:07 PM View: | Weyer Christian SVP, Research & Development | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 39 | $14.62 | $570.18 | < 1% 43.84K to 43.88K | |
| 26-Jul-12 8:06 PM View: | Foletta Mark G SVP, Chief Financial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 880 | $14.62 | $12,865.60 | 1% 84.44K to 85.32K | |
| 26-Jul-12 8:06 PM View: | Kolterman Orville G SVP, Chief Medical Officer | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 1,376 | $14.62 | $20,117.10 | < 1% 205.02K to 206.39K | |
| 26-Jul-12 8:06 PM View: | Mihalik Vincent P SVP, Chief Commercial Officer | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 890 | $14.62 | $13,011.80 | 2% 44.88K to 45.77K | |
| 26-Jul-12 8:06 PM View: | Gergen Mark J SVP, Corporate Development | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 936 | $14.62 | $13,684.30 | 1% 74.4K to 75.33K | |
| 26-Jul-12 8:06 PM View: | Rowland Lloyd A VP, Chief Compliance Officer | Amylin Pharmaceuticals Inc. (AMLN) | 25-Jul-12 | Grant | 823 | $14.62 | $12,032.30 | 2% 46.24K to 47.06K | |
| 24-May-12 4:41 PM View: | Gavin James R III Director | Amylin Pharmaceuticals Inc. (AMLN) | 24-May-12 | Disposition | 3,000 | -- | -- | (40%) 7.58K to 4.58K | |
| 24-May-12 4:41 PM View: | Beck Teresa Director | Amylin Pharmaceuticals Inc. (AMLN) | 24-May-12 | Disposition | 3,000 | -- | -- | (27%) 11.0K to 8.0K |
